Hodgkin's disease following extranodal marginal zone B-cell lymphoma in remission. [electronic resource]
Producer: 19990422Description: 96-100 p. digitalISSN:- 0925-5710
- Antigens, CD20 -- analysis
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Biomarkers, Tumor
- Combined Modality Therapy -- adverse effects
- Cyclophosphamide -- administration & dosage
- Diagnosis, Differential
- Doxorubicin -- administration & dosage
- Epstein-Barr Virus Infections -- diagnosis
- Fatal Outcome
- Female
- Gene Rearrangement
- Herpesvirus 4, Human -- isolation & purification
- Hodgkin Disease -- diagnosis
- Humans
- Immunophenotyping
- In Situ Hybridization
- Lymphoma, B-Cell, Marginal Zone -- drug therapy
- Lymphoma, Non-Hodgkin -- diagnosis
- Middle Aged
- Neoplasm Proteins -- analysis
- Neoplasms, Second Primary -- diagnosis
- Neoplastic Stem Cells -- chemistry
- Polymerase Chain Reaction
- Prednisone -- administration & dosage
- RNA, Viral -- analysis
- Receptors, Antigen, B-Cell -- analysis
- Reed-Sternberg Cells -- chemistry
- Remission Induction
- Vincristine -- administration & dosage
No physical items for this record
Publication Type: Case Reports; Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.